Boletis J - Search Results

1

Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis.

Sarafidis P, Agarwal R, Pitt B, Wanner C, Filippatos G, Boletis J, Tuttle KR, Ruilope LM, Rossing P, Toto R, Anker SD, Liu ZH, Joseph A, Ahlers C, Brinker M, Lawatscheck R, Bakris G; FIDELIO-DKD and FIGARO-DKD Investigators. Sarafidis P, et al. Among authors: boletis j. Clin J Am Soc Nephrol. 2023 Mar 17;18(5):602-12. doi: 10.2215/CJN.0000000000000149. Online ahead of print. Clin J Am Soc Nephrol. 2023. PMID: 36927680 Free PMC article.

2

Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study.

Krämer BK, Charpentier B, Bäckman L, Silva HT Jr, Mondragon-Ramirez G, Cassuto-Viguier E, Mourad G, Sola R, Rigotti P, Mirete JO; Tacrolimus Prolonged Release Renal Study Group. Krämer BK, et al. Am J Transplant. 2010 Dec;10(12):2632-43. doi: 10.1111/j.1600-6143.2010.03256.x. Epub 2010 Sep 14. Am J Transplant. 2010. PMID: 20840480 Free article. Clinical Trial.

3

The Han:SPRD Rat: A Preclinical Model of Polycystic Kidney Disease.

Kofotolios I, Bonios MJ, Adamopoulos M, Mourouzis I, Filippatos G, Boletis JN, Marinaki S, Mavroidis M. Kofotolios I, et al. Among authors: boletis jn. Biomedicines. 2024 Feb 3;12(2):362. doi: 10.3390/biomedicines12020362. Biomedicines. 2024. PMID: 38397964 Free PMC article. Review.

4

Assessment of Donor Derived Cell Free DNA (dd-cfDNA) at Surveillance and at Clinical Suspicion of Acute Rejection in Renal Transplantation.

Mantios E, Filiopoulos V, Constantoulakis P, Liapis G, Vittoraki A, Casas S, Marinaki S, Boletis JN. Mantios E, et al. Among authors: boletis jn. Transpl Int. 2023 Oct 13;36:11507. doi: 10.3389/ti.2023.11507. eCollection 2023. Transpl Int. 2023. PMID: 37901296 Free PMC article.

5

EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.

Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, Boletis J, Bruce IN, Cervera R, Doria A, Dörner T, Furie RA, Gladman DD, Houssiau FA, Inês LS, Jayne D, Kouloumas M, Kovács L, Mok CC, Morand EF, Moroni G, Mosca M, Mucke J, Mukhtyar CB, Nagy G, Navarra S, Parodis I, Pego-Reigosa JM, Petri M, Pons-Estel BA, Schneider M, Smolen JS, Svenungsson E, Tanaka Y, Tektonidou MG, Teng YO, Tincani A, Vital EM, van Vollenhoven RF, Wincup C, Bertsias G, Boumpas DT. Fanouriakis A, et al. Among authors: boletis j. Ann Rheum Dis. 2024 Jan 2;83(1):15-29. doi: 10.1136/ard-2023-224762. Ann Rheum Dis. 2024. PMID: 37827694

6

Multidisciplinary approach to lupus nephritis: Clinical pearls, pitfalls, and positioning of newly-approved agents.

Fanouriakis A, Bertsias G, Liapis G, Marinaki S, Papagianni A, Stangou M, Garyfallos A, Lionaki S, Tektonidou MG, Boletis JN, Boumpas DT. Fanouriakis A, et al. Among authors: boletis jn. Lupus. 2023 Sep;32(10):1155-1163. doi: 10.1177/09612033231191944. Epub 2023 Jul 27. Lupus. 2023. PMID: 37499240 Review.

7

Clinical Outcome of Kidney Transplant Recipients with C1q-Binding De Novo Donor Specific Antibodies: A Single-Center Experience.

Marinaki S, Vittoraki A, Tsiakas S, Kofotolios I, Darema M, Ioannou S, Vallianou K, Boletis J. Marinaki S, et al. Among authors: boletis j. J Clin Med. 2023 Jul 4;12(13):4475. doi: 10.3390/jcm12134475. J Clin Med. 2023. PMID: 37445510 Free PMC article.

8

Disease modification achievement in patients with lupus nephritis in a real-life setting: mission impossible?

Panagiotopoulos A, Kapsia E, Michelakis I, Boletis J, Marinaki S, Sfikakis PP, Tektonidou MG. Panagiotopoulos A, et al. Among authors: boletis j. RMD Open. 2023 Jun;9(2):e003158. doi: 10.1136/rmdopen-2023-003158. RMD Open. 2023. PMID: 37308249 Free PMC article.

9

Predictors of Early Response, Flares, and Long-Term Adverse Renal Outcomes in Proliferative Lupus Nephritis: A 100-Month Median Follow-Up of an Inception Cohort.

Kapsia E, Marinaki S, Michelakis I, Liapis G, Sfikakis PP, Boletis J, Tektonidou MG. Kapsia E, et al. Among authors: boletis j. J Clin Med. 2022 Aug 26;11(17):5017. doi: 10.3390/jcm11175017. J Clin Med. 2022. PMID: 36078950 Free PMC article.

10

A past medical history of autoimmune disease predicts a future with fewer relapses in patients with ANCA-associated vasculitis.

Lionaki S, Marinaki S, Fragkioudaki S, Bellos I, Kalaitzakis E, Kalogeropoulos P, Liapis G, Tzioufas AG, Boletis JN. Lionaki S, et al. Among authors: boletis jn. Clin Exp Rheumatol. 2022 May;40(4):741-750. doi: 10.55563/clinexprheumatol/acphbb. Epub 2022 May 4. Clin Exp Rheumatol. 2022. PMID: 35522540 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

202 results

Search Page